Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study
{{output}}
Background: Biologic agents have transformed moderate-to-severe psoriasis treatment, but their real-world effect on lipid-derived cardiovascular risk markers remains unclear. ... ...
